US Stock MarketDetailed Quotes

INKT MiNK Therapeutics

Watchlist
  • 0.871
  • -0.019-2.08%
Trading Apr 25 09:46 ET
30.21MMarket Cap-1339P/E (TTM)

About MiNK Therapeutics Company

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.

Company Profile

SymbolINKT
Company NameMiNK Therapeutics
Listing DateOct 15, 2021
Issue Price12.00
Founded2017
CEODr. Jennifer S. Buell, PhD
MarketNASDAQ
Employees31
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address149 5th Avenue,Suite 500
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10010
Phone1-212-994-8250
Websitehttp://www.minktherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jennifer S. Buell, PhD
  • President, Chief Executive Officer and Director
  • 3.87M
  • Marc van Dijk
  • Chief Scientific Officer
  • 651.17K
  • Christine M. Klaskin
  • Treasurer, Principal Financial Officer and Principal Accounting Officer
  • 27.24K
  • Dr. Garo H. Armen, Pd.D
  • Chairman of the Board
  • 1.50M
  • Barbara Ryan
  • Independent Director
  • 119.00K
  • Peter Behner
  • Independent Director
  • 90.30K
  • Brian J. Corvese
  • Independent Director
  • 119.50K
  • Ulf Wiinberg
  • Independent Director
  • 84.80K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg